Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group (Q77873031)
Jump to navigation
Jump to search
scientific article published on 01 June 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group |
scientific article published on 01 June 1999 |
Statements
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group (English)
Hochberg MC
Ross PD
Black D
Cummings SR
Genant HK
Nevitt MC
Musliner T